Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest Wearable Defibrillator. New results from the Prospective Registry of Patients Using the Wearable Defibrillator (WEARIT-II Registry) were presented by Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, during the Late-Breaking Clinical Trials session at CardioStim/EuroPace 2016.

In a recent report on satisfaction among healthcare information technology (IT) customers, Agfa HealthCare customers reported high levels of satisfaction with the company's products and service.

Medtronic plc announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator (ICD) therapy at Cardiostim/EHRA Europace 2016, the World Congress in Electrophysiology and Cardiac Techniques, in Nice, France.

After following a large sub-set of patients, researchers found that by using strain echocardiography they could accurately predict which patients were likely to have complications from hypertrophic cardiomyopathy (HCM).

While 3-D printing has been around since the mid-1980s, there is accumulating evidence that this technology has the potential to revolutionize the understanding and management of heart conditions.

Two new research studies verify that echocardiography, linked to experts through telemedicine, can provide better and more economical clinical healthcare to patients living a great distance from a cardiac care center.